Literature DB >> 23975870

Is CGRP a marker for chronic migraine?

Stephen D Silberstein1, Lars Edvinsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23975870     DOI： 10.1212/WNL.0b013e3182a6cc33

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

Review 1.  Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.

Authors:  Marcelo E Bigal; Sarah Walter
Journal:  CNS Drugs       Date:  2014-05       Impact factor: 5.749

Review 2.  TEV-48125: a review of a monoclonal CGRP antibody in development for the preventive treatment of migraine.

Authors:  Sarah Walter; Marcelo E Bigal
Journal:  Curr Pain Headache Rep       Date:  2015-03

3.  Role of calcitonin gene-related peptide in functional adaptation of the skeleton.

Authors:  Susannah J Sample; Caitlin M Heaton; Mary Behan; Jason A Bleedorn; Molly A Racette; Zhengling Hao; Peter Muir
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

4.  Fremanezumab: First Global Approval.

Authors:  Sheridan M Hoy
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

5.  Diagnosis and treatment for chronic migraine.

Authors:  Maureen Moriarty; Theresa Mallick-Searle
Journal:  Nurse Pract       Date:  2016-06-19

6.  Impact of Food Components on in vitro Calcitonin Gene-Related Peptide Secretion-A Potential Mechanism for Dietary Influence on Migraine.

Authors:  Margaret Slavin; Julia Bourguignon; Kyle Jackson; Michael-Angelo Orciga
Journal:  Nutrients       Date:  2016-07-01       Impact factor: 5.717
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.